ReviewThe Cochrane database of systematic reviews2023
Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon.
Nancy Maltez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it